| International uniform response criteria for multiple myeloma BGM Durie, JL Harousseau, JS Miguel, J Blade, B Barlogie, K Anderson, ... Leukemia 20 (9), 1467-1473, 2006 | 3558 | 2006 |
| BET bromodomain inhibition as a therapeutic strategy to target c-Myc JE Delmore, GC Issa, ME Lemieux, PB Rahl, J Shi, HM Jacobs, E Kastritis, ... Cell 146 (6), 904-917, 2011 | 3234 | 2011 |
| 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans R Wilson, R Ainscough, K Anderson, C Baynes, M Berks, J Bonfield, ... Nature 368 (6466), 32-38, 1994 | 1838 | 1994 |
| Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ... New England Journal of Medicine 365 (15), 1384-1395, 2011 | 1492 | 2011 |
| Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 SV Rajkumar, JL Harousseau, B Durie, KC Anderson, M Dimopoulos, ... Blood, The Journal of the American Society of Hematology 117 (18), 4691-4695, 2011 | 1190 | 2011 |
| High-throughput oncogene mutation profiling in human cancer RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ... Nature genetics 39 (3), 347-351, 2007 | 1176 | 2007 |
| The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee E Campo, ES Jaffe, JR Cook, L Quintanilla-Martinez, SH Swerdlow, ... Blood, The Journal of the American Society of Hematology 140 (11), 1229-1253, 2022 | 1062 | 2022 |
| Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma PG Richardson, RL Schlossman, E Weller, T Hideshima, C Mitsiades, ... Blood, The Journal of the American Society of Hematology 100 (9), 3063-3067, 2002 | 1060 | 2002 |
| Expression of Epstein–Barr virus transformation–associated genes in tissues of patients with EBV lymphoproliferative disease L Young, C Alfieri, K Hennessy, H Evans, C O'Hara, KC Anderson, J Ritz, ... New England Journal of Medicine 321 (16), 1080-1085, 1989 | 887 | 1989 |
| Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology CA Schiffer, KC Anderson, CL Bennett, S Bernstein, LS Elting, ... Journal of clinical oncology 19 (5), 1519-1538, 2001 | 818 | 2001 |
| A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside A Pestronk, DR Cornblath, AA Ilyas, H Baba, RH Quarles, JW Griffin, ... Annals of Neurology: Official Journal of the American Neurological …, 1988 | 766 | 1988 |
| Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321 B Barlogie, RA Kyle, KC Anderson, PR Greipp, HM Lazarus, DD Hurd, ... Journal of clinical oncology 24 (6), 929-936, 2006 | 674 | 2006 |
| Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy TN Chonghaile, KA Sarosiek, TT Vo, JA Ryan, A Tammareddi, ... Science 334 (6059), 1129-1133, 2011 | 661 | 2011 |
| American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma JR Berenson, BE Hillner, RA Kyle, K Anderson, A Lipton, GC Yee, ... Journal of Clinical Oncology 20 (17), 3719-3736, 2002 | 655 | 2002 |
| American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma RA Kyle, GC Yee, MR Somerfield, PJ Flynn, S Halabi, S Jagannath, ... Journal of Clinical Oncology 25 (17), 2464-2472, 2007 | 526 | 2007 |
| Presentation of viral antigen controlled by a gene in the major histocompatibility complex V Cerundolo, J Alexander, K Anderson, C Lamb, P Cresswell, ... Nature 345 (6274), 449-452, 1990 | 499 | 1990 |
| Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies GS Cowley, BA Weir, F Vazquez, P Tamayo, JA Scott, S Rusin, ... Scientific data 1 (1), 1-12, 2014 | 493 | 2014 |
| Longitudinal molecular trajectories of diffuse glioma in adults FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ... Nature 576 (7785), 112-120, 2019 | 484 | 2019 |
| History of the development of arsenic derivatives in cancer therapy S Waxman, KC Anderson The oncologist 6 (S2), 3-10, 2001 | 477 | 2001 |
| A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis BA Walker, K Mavrommatis, CP Wardell, TC Ashby, M Bauer, F Davies, ... Leukemia 33 (1), 159-170, 2019 | 471 | 2019 |
